国内咳嗽诊疗指南的质量评价  

Quality Assessment of Clinical Practice Guidelines for Diagnosis and Management of Cough in China

作　　者：江梅[1] 廖理粤[1] 罗炜[1] 谢燕清[1] 赖克方[1] 

机构地区：[1]广州医科大学附属第一医院呼吸疾病国家重点实验室,广州呼吸疾病研究所,广州510120

出　　处：《中国循证医学杂志》2015年第4期409-413,共5页Chinese Journal of Evidence-based Medicine

摘　　要：目的评价国内咳嗽诊疗指南的质量,了解当前指南存在的问题,为今后更新和制定我国临床实践指南提供方法学参考。方法计算机检索Wan Fang Data、CNKI、VIP和CBM数据库及中国临床指南网站,然后利用指南质量评价工具AGREEⅡ对入选指南的质量进行评价。结果共纳入6个指南,AGREEⅡ6个领域的平均得分情况分别为"范围和目的"61.1%、"参与人员"26.6%、"制定的严谨性"16.7%、"表达的明晰性"58.3%、"应用性"11.1%、"编辑独立性"0%。结论国内咳嗽诊疗指南质量不高,特别需在指南开发方法的严谨性和指南报告规范方面加强。Objectives To assess the quality of clinical practice guidelines（CPGs） for diagnosis and management of cough in China, and to provide methodological experiences for updating and developing the evidence-based guideline in this field in future. Methods We searched CBM, Wan Fang Data, VIP and CNKI databases, and Chinese clinical guidelines＇ website to identify and select CPGs related to cough in China. Four reviewers independently evaluated the quality of eligible guidelines using the Appraisal of Guidelines for Research and Evaluation（AGREE） II instrument. Results Six guidelines were included. The mean scores for six AGREE II domains were low： scope and purpose 61.1%, stakeholder involvement 26.6%, rigor of development 16.7%, clarity and presentation 58.3%, applicability 11.1%, and editorial independence 0.0%. Conclusions The quality of guidelines for cough in China is low. More efforts are urgently needed to develop high quality Chinese guidelines using methodologically rigorous development frameworks and strengthen guideline reporting.

关 键 词：咳嗽 临床实践指南 质量评价 AGREEⅡ 

分 类 号：R56[医药卫生—呼吸系统]